Ionis Pharmaceuticals, Inc., a specialist in RNA-targeted therapeutics, has appointed C. Frank Bennett, Ph.D., as chief scientific officer, and Eric E. Swayze, Ph.D., as senior vice president of research, effective January 1, 2020.  In his new role, Dr. Bennett will lead a new program to identify technologies to enhance Ionis’ drug discovery programs and identify potential new therapeutic platforms. Dr. Bennett will continue in his current role as Franchise Leader for Neurology Drug Dis...